Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cepheid (NASDAQ:CPHD)

52.69
Delayed Data
As of 3:59pm ET
 +0.06 / +0.11%
Today’s Change
25.09
Today|||52-Week Range
53.91
+44.24%
Year-to-Date
Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Sep 20 / Zacks.com - Paid Partner Content
Cepheid Announces Expansion of Molecular C. Difficile Product
Sep 16 / Zacks.com - Paid Partner Content
Why GenMark Diagnostics, Inc. Is Soaring Today
Sep 16 / MotleyFool.com - Paid Partner Content
Cepheid's (CPHD) Shares March Higher, Can It Continue?
Sep 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close52.63
Today’s open52.62
Day’s range52.56 - 52.78
Volume1,541,507
Average volume (3 months)1,464,717
Market cap$3.8B
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+6.94%
Earnings growth (this year)+33.50%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+13.06%
P/E ratioNM
Price/Sales4.95
Price/Book10.30

Competitors

 Today’s
change
Today’s
% change
BIOBio Rad Laboratories...-0.08-0.05%
BRKRBruker Corp+0.08+0.35%
PKIPerkinElmer Inc+0.13+0.23%
AXDXAccelerate Diagnosti...-0.04-0.15%
Data as of 4:14pm ET, 09/28/2016

Financials

Next reporting dateOctober 13, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$531.1M
Annual profit (last year)-$48.5M
Net profit margin-9.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John L. Bishop
President &
Chief Operating Officer
Warren C. Kocmond
Corporate headquarters
Sunnyvale, California

Forecasts

Search for Jobs